Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Kymera and GSK collaborate to accelerate discovery of protein-degrading therapeutics

April 5, 2018

Q-State Biosciences enters drug discovery collaboration with Vertex

April 5, 2018

Researchers discover novel phyllanthusmin analog PHY-34

March 22, 2018

Novartis presents novel potent OGG1 inhibitor

March 16, 2018

AbbVie gains rights to discovery programs from X-Chem

March 14, 2018

Enteris signs feasibility development agreement with Ferring

March 6, 2018

Novartis presents novel SPPL2a inhibitor as a potent immunomodulator

March 2, 2018

Novartis and Pear to collaborate on prescription software applications for schizophrenia and MS

March 1, 2018

BMS licenses Domain Therapeutics' bioSens-All technology

Feb. 28, 2018

Researchers discover OAT-2068, a highly selective and orally bioavailable inhibitor of mCHIT1

Feb. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...